Bilstraat 106

3572 BJ, Utrecht, the Netherlands

info@virology-education.com

  • White Twitter Icon
  • White LinkedIn Icon
  • White Facebook Icon

Tel: +31 (0)30 230 7140
Fax: +31 (0)30 230 7148

© 2019 by Virology Education

Managing Today's Complex HIV Patient 2019
complex HIV 01.jpg

Michael Kozal, MD
Yale University, United States

In this 16-minute highlight video, Dr. Michael Kozal talks about how to identify the complex HIV patient & approach to treatment.

complex HIV patient 02.jpg

Daniel Kuritzkes, MD
Harvard Medical School, United States

In this 16-minute highlight video, Dr. Daniel Kuritzkes talks about drug options for the complex HIV patient: what are they and how best to use them? 

Complex HIV 03.jpg

David Hardy, MD, AAHIVS

Johns Hopkins University School of Medicine,
United States

In this 10-minute highlight video, Dr. David Hardy talks about Managing the complex patient with multiple comorbidities.

 

Format: Online Course

Publish Date: 24 October 2019 

 

Expiry Date: 24 October 2020 

FACULTY

Michael Kozal, MD
Yale University, United States


Daniel Kuritzkes, MD
Harvard Medical School, United States


David Hardy, MD, AAHIVS
Johns Hopkins University School of Medicine, United States



The global epidemic of human immunodeficiency virus-1 (HIV-1) virus infections continues to present a significant health burden with approximately 1 million HIV patients in the US. Despite improved antiretroviral regimens, emergence of resistance in patients taking first line regimens occurs frequently. Such patients rely upon second and later line therapeutics. Presently there are limited options for complex patients that have multiple treatment failures and resistance.

Renewed attention to an increasing number of HIV patients with limited treatment options, the so-called complex HIV patient can be given, due to impressive data emerging from advanced stage clinical trials with new agents.
This brings an educational need for health care professionals managing these patients in terms of adherence, resistance, ageing, comorbidities & polypharmacy, as well as in updating their knowledge and expertise on existing and new antiretroviral therapeutics for optimizing treatment of these complex HIV patients.



LEARNING OBJECTIVES


After participating in the full program ( three modules ), you will have:
• Improved knowledge of the definition on complex patients and the challenges of their care
• Acquired understanding on how best to identify the complex HIV patient in your clinical practice
• Greater understanding of the new treatment options available for these patients
• Learned how best to integrate these new drugs in to optimal combination regimens
• Improved skills on managing drug-drug interactions and toxicities in these complex patients



NEEDS ASSESSMENT


Despite improved antiretroviral regimens in HIV treatment, virological failure and emergence of drug resistance is still a problem worldwide. This includes both patients recently infected as well as those veterans of older regimens: in the USA, the overall viral suppression among PLWHIV is 55% and adherence is often sub optimal.
Ultimately, this leads to an increasing number of HIV patients with limited treatment options who require greater knowledge and understanding to manage in terms of adherence, resistance, ageing, comorbidities and polypharmacy – they are complex HIV patients. This highlights program aims to help healthcare professionals identify and manage the complex HIV patient, as well as providing education on new antiretroviral drugs for optimizing treatment of complex HIV patients.

ACKNOWLEDGEMENTS

Provided by Virology Education.

This activity has been made possible by an unrestricted educational grant from ViiV Healthcare.